Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 1.789 Q1 | 103 | 89 | 255 | 9901 | 1288 | 238 | 4.31 | 111.25 | 36.86 | |
2 | Current Molecular Pharmacology | journal | 1.560 Q1 | 49 | 39 | 59 | 3998 | 291 | 57 | 4.38 | 102.51 | 40.00 | |
3 | Current Medicinal Chemistry | journal | 1.538 Q1 | 202 | 504 | 1001 | 59089 | 5168 | 970 | 4.57 | 117.24 | 39.58 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 1.492 Q1 | 96 | 123 | 237 | 9055 | 913 | 208 | 3.68 | 73.62 | 38.30 | |
5 | Current Drug Targets | journal | 1.332 Q1 | 119 | 194 | 483 | 18772 | 1881 | 438 | 4.21 | 96.76 | 34.09 | |
6 | Current Pharmaceutical Design | journal | 1.280 Q1 | 183 | 585 | 1163 | 65504 | 4819 | 1058 | 3.77 | 111.97 | 37.84 | |
7 | Open Medicinal Chemistry Journal | journal | 1.174 Q1 | 23 | 4 | 20 | 140 | 81 | 18 | 4.26 | 35.00 | 40.00 | |
8 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.027 Q2 | 108 | 121 | 293 | 11637 | 971 | 261 | 3.00 | 96.17 | 40.32 | |
9 | Current Vascular Pharmacology | journal | 0.975 Q2 | 69 | 107 | 217 | 8016 | 744 | 205 | 3.15 | 74.92 | 27.27 | |
10 | Mini-Reviews in Medicinal Chemistry | journal | 0.941 Q2 | 107 | 140 | 364 | 12246 | 1255 | 356 | 3.41 | 87.47 | 35.18 | |
11 | Current Neuropharmacology | journal | 0.799 Q2 | 103 | 35 | 170 | 4661 | 494 | 162 | 2.30 | 133.17 | 30.39 | |
12 | Reviews on Recent Clinical Trials | journal | 0.683 Q2 | 35 | 42 | 79 | 2507 | 186 | 79 | 2.00 | 59.69 | 35.81 | |
13 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 61 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | 36.72 | |
14 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.502 Q3 | 43 | 34 | 78 | 3271 | 168 | 78 | 1.96 | 96.21 | 32.65 | |
15 | Journal of Toxicology | journal | 0.454 Q3 | 47 | 61 | 56 | 3651 | 118 | 56 | 2.11 | 59.85 | 39.64 | |
16 | Current Drug Safety | journal | 0.428 Q3 | 41 | 63 | 136 | 2743 | 228 | 124 | 1.49 | 43.54 | 35.16 | |
17 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.412 Q3 | 45 | 23 | 83 | 1226 | 111 | 77 | 1.38 | 53.30 | 37.50 | |
18 | Anti-Infective Agents | journal | 0.399 Q3 | 26 | 27 | 43 | 1255 | 59 | 40 | 1.22 | 46.48 | 34.00 | |
19 | Current Radiopharmaceuticals | journal | 0.392 Q3 | 32 | 45 | 95 | 2173 | 99 | 86 | 1.23 | 48.29 | 33.11 | |
20 | Current Pharmacogenomics and Personalized Medicine | journal | 0.368 Q3 | 20 | 41 | 89 | 2194 | 140 | 72 | 1.24 | 53.51 | 44.66 | |
21 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.235 Q3 | 17 | 34 | 78 | 2748 | 37 | 70 | 0.39 | 80.82 | 28.45 | |
22 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.183 Q3 | 27 | 35 | 109 | 2441 | 66 | 98 | 0.47 | 69.74 | 51.65 | |
23 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.102 Q4 | 10 | 13 | 59 | 408 | 3 | 59 | 0.06 | 31.38 | 44.44 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®